Methodological challenges in translational drug response modeling in cancer: A systematic analysis with FORESEE.

Translational models directly relating drug response specific processes that can be observed in vitro to their in vivo role in cancer patients constitute a crucial part of the development of personalized medication. Unfortunately, current studies often focus on the optimization of isolated model cha...

Full description

Bibliographic Details
Main Authors: Lisa-Katrin Schätzle, Ali Hadizadeh Esfahani, Andreas Schuppert
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-04-01
Series:PLoS Computational Biology
Online Access:https://doi.org/10.1371/journal.pcbi.1007803
_version_ 1818579079712997376
author Lisa-Katrin Schätzle
Ali Hadizadeh Esfahani
Andreas Schuppert
author_facet Lisa-Katrin Schätzle
Ali Hadizadeh Esfahani
Andreas Schuppert
author_sort Lisa-Katrin Schätzle
collection DOAJ
description Translational models directly relating drug response specific processes that can be observed in vitro to their in vivo role in cancer patients constitute a crucial part of the development of personalized medication. Unfortunately, current studies often focus on the optimization of isolated model characteristics instead of examining the overall modeling workflow and the interplay of the individual model components. Moreover, they are often limited to specific data sets only. Therefore, they are often confined by the irreproducibility of the results and the non-transferability of the approaches into other contexts. In this study, we present a thorough investigation of translational models and their ability to predict the drug responses of cancer patients originating from diverse data sets using the R-package FORESEE. By systematically scanning the modeling space for optimal combinations of different model settings, we can determine models of extremely high predictivity and work out a few modeling guidelines that promote simplicity. Yet, we identify noise within the data, sample size effects, and drug unspecificity as factors that deteriorate the models' robustness. Moreover, we show that cell line models of high accuracy do not necessarily excel in predicting drug response processes in patients. We therefore hope to motivate future research to consider in vivo aspects more carefully to ultimately generate deeper insights into applicable precision medicine.
first_indexed 2024-12-16T06:56:00Z
format Article
id doaj.art-5125a6b8b8fa4e7e8915ecc6b391ea10
institution Directory Open Access Journal
issn 1553-734X
1553-7358
language English
last_indexed 2024-12-16T06:56:00Z
publishDate 2020-04-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Computational Biology
spelling doaj.art-5125a6b8b8fa4e7e8915ecc6b391ea102022-12-21T22:40:17ZengPublic Library of Science (PLoS)PLoS Computational Biology1553-734X1553-73582020-04-01164e100780310.1371/journal.pcbi.1007803Methodological challenges in translational drug response modeling in cancer: A systematic analysis with FORESEE.Lisa-Katrin SchätzleAli Hadizadeh EsfahaniAndreas SchuppertTranslational models directly relating drug response specific processes that can be observed in vitro to their in vivo role in cancer patients constitute a crucial part of the development of personalized medication. Unfortunately, current studies often focus on the optimization of isolated model characteristics instead of examining the overall modeling workflow and the interplay of the individual model components. Moreover, they are often limited to specific data sets only. Therefore, they are often confined by the irreproducibility of the results and the non-transferability of the approaches into other contexts. In this study, we present a thorough investigation of translational models and their ability to predict the drug responses of cancer patients originating from diverse data sets using the R-package FORESEE. By systematically scanning the modeling space for optimal combinations of different model settings, we can determine models of extremely high predictivity and work out a few modeling guidelines that promote simplicity. Yet, we identify noise within the data, sample size effects, and drug unspecificity as factors that deteriorate the models' robustness. Moreover, we show that cell line models of high accuracy do not necessarily excel in predicting drug response processes in patients. We therefore hope to motivate future research to consider in vivo aspects more carefully to ultimately generate deeper insights into applicable precision medicine.https://doi.org/10.1371/journal.pcbi.1007803
spellingShingle Lisa-Katrin Schätzle
Ali Hadizadeh Esfahani
Andreas Schuppert
Methodological challenges in translational drug response modeling in cancer: A systematic analysis with FORESEE.
PLoS Computational Biology
title Methodological challenges in translational drug response modeling in cancer: A systematic analysis with FORESEE.
title_full Methodological challenges in translational drug response modeling in cancer: A systematic analysis with FORESEE.
title_fullStr Methodological challenges in translational drug response modeling in cancer: A systematic analysis with FORESEE.
title_full_unstemmed Methodological challenges in translational drug response modeling in cancer: A systematic analysis with FORESEE.
title_short Methodological challenges in translational drug response modeling in cancer: A systematic analysis with FORESEE.
title_sort methodological challenges in translational drug response modeling in cancer a systematic analysis with foresee
url https://doi.org/10.1371/journal.pcbi.1007803
work_keys_str_mv AT lisakatrinschatzle methodologicalchallengesintranslationaldrugresponsemodelingincancerasystematicanalysiswithforesee
AT alihadizadehesfahani methodologicalchallengesintranslationaldrugresponsemodelingincancerasystematicanalysiswithforesee
AT andreasschuppert methodologicalchallengesintranslationaldrugresponsemodelingincancerasystematicanalysiswithforesee